Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidharth Mehan

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Current Pharmaceutical Design|October 27, 2025
Gender-Based Disparities in Knowledge, Attitudes, and Practices Among Type-II Diabetes Patients in Punjab, India: Insights for Tailored InterventionsSandeep Kaur, Sidharth Mehan, Ghanshyam Das Gupta
Journal of Clinical Medicine|July 14, 2023
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment ChallengesZuber Khan, Ghanshyam Das Gupta, Sidharth Mehan
Neurotoxicity Research|February 14, 2022
Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological DysfunctionsBidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, et al.
Neurotoxicology|August 7, 2023
Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterationsPranshul Sethi, Sidharth Mehan, Zuber Khan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2021
Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other DysfunctionsNidhi Sharma, Ambika Shandilya, Nitish Kumar, et al.
Current Pharmaceutical Design|July 30, 2025
Navigating the Complex Landscape of Autism Spectrum Disorder: Challenges and Opportunities in Diagnosis, Treatment, and SupportsArun Kumar Sharma, Sant Kumar Verma, Sidharth Mehan
Journal of Molecular Neuroscience : MN|September 30, 2010
JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalitiesSidharth Mehan, Harikesh Meena, Deepak Sharma, et al.
Neurotoxicology|February 6, 2026
Neuroprotection via IGF-1 Neuronal Signaling Activation by Melatonin and Edaravone Synergy in Methylmercury-Induced ALS-like Neurotoxicity: Comprehensive Analysis of Brain Regions, Spinal Cord, CSF, and Blood PlasmaGurudev Singh Raina, Sidharth Mehan, Ghanshyam Das Gupta
Bioorganic Chemistry|July 24, 2025
Dual α-amylase and α-glucosidase inhibitors: recent progress from natural and synthetic resourcesRitesh Jha, Kamya Goyal, Sidharth Mehan, et al.
RSC Medicinal Chemistry|August 16, 2024
Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, <i>in vitro</i> and <i>in vivo</i> anti-diabetic evaluationGurpreet Singh, Rajveer Singh, Vikramdeep Monga, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Current Pharmaceutical Design|October 27, 2025
Gender-Based Disparities in Knowledge, Attitudes, and Practices Among Type-II Diabetes Patients in Punjab, India: Insights for Tailored InterventionsSandeep Kaur, Sidharth Mehan, Ghanshyam Das Gupta
Journal of Clinical Medicine|July 14, 2023
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment ChallengesZuber Khan, Ghanshyam Das Gupta, Sidharth Mehan
Neurotoxicity Research|February 14, 2022
Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological DysfunctionsBidisha Rajkhowa, Sidharth Mehan, Pranshul Sethi, et al.
Neurotoxicology|August 7, 2023
Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterationsPranshul Sethi, Sidharth Mehan, Zuber Khan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2021
Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other DysfunctionsNidhi Sharma, Ambika Shandilya, Nitish Kumar, et al.
Current Pharmaceutical Design|July 30, 2025
Navigating the Complex Landscape of Autism Spectrum Disorder: Challenges and Opportunities in Diagnosis, Treatment, and SupportsArun Kumar Sharma, Sant Kumar Verma, Sidharth Mehan
Journal of Molecular Neuroscience : MN|September 30, 2010
JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalitiesSidharth Mehan, Harikesh Meena, Deepak Sharma, et al.
Neurotoxicology|February 6, 2026
Neuroprotection via IGF-1 Neuronal Signaling Activation by Melatonin and Edaravone Synergy in Methylmercury-Induced ALS-like Neurotoxicity: Comprehensive Analysis of Brain Regions, Spinal Cord, CSF, and Blood PlasmaGurudev Singh Raina, Sidharth Mehan, Ghanshyam Das Gupta
Bioorganic Chemistry|July 24, 2025
Dual α-amylase and α-glucosidase inhibitors: recent progress from natural and synthetic resourcesRitesh Jha, Kamya Goyal, Sidharth Mehan, et al.
RSC Medicinal Chemistry|August 16, 2024
Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, <i>in vitro</i> and <i>in vivo</i> anti-diabetic evaluationGurpreet Singh, Rajveer Singh, Vikramdeep Monga, et al.
Pageof 13